Open Insider Trading Activity for Renovorx, Inc. Chief Medical Officer Agah Ramtin
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RNXT | 2026-01-22 | 2026-01-21 | Renovorx, Inc. | Agah Ramtin | Chief Medical Officer | Buy | 1 | 10,000 | $1.00 | $10,000.00 | 1.25% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RNXT | 2026-01-05 | 2025-12-31 | Renovorx, Inc. | Agah Ramtin | Chief Medical Officer | Buy | 1 | 9,795 | $0.86 | $8,423.70 | 1.24% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RNXT | 2026-01-02 | 2025-12-30 | Renovorx, Inc. | Agah Ramtin | Chief Medical Officer | Buy | 1 | 205 | $0.83 | $170.15 | 0.03% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RNXT | 2025-12-08 | 2025-12-05 | Renovorx, Inc. | Agah Ramtin | Chief Medical Officer | Buy | 1 | 10,000 | $0.96 | $9,600.00 | 1.30% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RNXT | 2025-04-17 | 2025-04-15 | Renovorx, Inc. | Agah Ramtin | Chief Medical Officer | Buy | 1 | 15,000 | $0.90 | $13,500.00 | 1.35% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RNXT | 2025-04-10 | 2025-04-09 | Renovorx, Inc. | Agah Ramtin | Chief Medical Officer | Buy | 1 | 30,000 | $0.81 | $24,300.00 | 2.78% | View Filing |